# Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid

> **NCT04411914** · PHASE1 · COMPLETED · sponsor: **Temple University** · enrollment: 13 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Clavulanic Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04411914
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2021-11-23
- **Final completion:** 2022-03-31
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04411914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04411914, "Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04411914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*